close

Вход

Забыли?

вход по аккаунту

?

Combinatorial Chemistry P. Seeberger Recognized Medicinal Chemistry R. Metternich on Board Pharmaceutical Chemistry G. Wess Directs GSF

код для вставкиСкачать
News
R. Metternich Takes On
Responsibility for Schering
Research
P. Seeberger Receives ESCS Award
Peter H. Seeberger (ETH Zrich)
received the European Society of Combinatorial Sciences (ESCS) Award for
his outstanding contribution to combinatorial carbohydrate chemistry. He
presented his award lecture on “Automated Synthesis of Oligosaccharides:
From Carbohydrate Arrays
to Vaccines” at the Eurocombi-3 Conference.
Seeberger
studied
chemistry at the Universit+t
Erlangen-Nrnberg
and
received
his
doctorate
under the guidance of M.
Caruthers (University of
Colorado) in 1995. After a
postdoctoral stay in the
group of S. Danishefsky at
P. Seeberger
the Sloan–Kettering Institute in New York, he
began his independent research at the
Massachussets Institute of Technology,
where he became professor in 2002. A
year later, he accepted a chair as professor of organic chemistry (successor to
Dieter Seebach) at the ETH Zrich.
Seeberger:s research interest lies at the
interface between chemistry and biology, with particular regard to glycoproteins and glycolipids. He recently
reported in Angewandte Chemie on an
anthrax tetrasaccharide antigen as a
candidate vaccine against anthrax.[1]
Seeberger is a member of the editorial
board for QSAR & Combinatorial Science.
7330
From January 1, 2006, Rainer Metternich will join the board of Schering AG
and be responsible for the research
division. In 2000, he joined Schering
AG in Berlin as director of medicinal
chemistry,
and
since 2001 he has
led the European
Research Center
there.
Between
1986 and 1997 he
moved up the ranks
in pharmaceutical
research at Sandoz
AG in Basel from
laboratory to division leader. From
R. Metternich
1997 to 2000 he
worked as a senior
chemistry expert and member of the
global research management committee
at Novartis.
Metternich studied chemical engineering in Jlich (Germany), then
chemistry at the Universit+t Marburg,
where he completed his PhD in 1985
with R. W. Hoffmann on topics including the configurational stability of chiral
organometallic reagents.[2] During a
postdoctoral stay with D. A. Evans at
Harvard University in Cambridge, MA
(USA), he worked on stereoselective
synthesis and the total synthesis of
natural products. In 2001, he was
named Honorary Professor of Organic
Chemistry at the Technische Universit+t
Berlin (Germany). Since 2004, Metternich has been a board member of the
German Chemical Society (GDCh) as
well as an editorial board member for
Angewandte Chemie.
G. Wess Directs GSF Center
Gnther Wess (formerly at SanofiAventis, Frankfurt/M) succeeds E.-G.
Afting as Scientific and Technical Director at the GSF – National Research
Center for Environment and Health in
Neuherberg (near Munich) from
2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
November 1, 2005. The Company for
Radiation Research (Gesellschaft fr
Strahlenforschung, GSF) is a member
of the Helmholtz Association of
German Research Centers and is
funded by the Federal Republic of
Germany as well as the State of Bavaria.
Wess studied at the Universit+t
Frankfurt (Germany) and earned his
habilitation in pharmaceutical chemistry
from the Universit+t Mainz in 1999.
Since 2000, he has been Honorary
Professor at the Johann-WolfgangGoethe-Universit+t, Frankfurt. Wess
began his career in
1982 at Hoeschst
AG.
After
a
research stay with
E. J. Corey (Harvard University),
he went on to
become leader of
the
medicinal
development division at Hoechst
Marion
Roussel
(Germany) in 1998 G. Wess
and its successor
company Aventis, which merged into
Sanofi–Aventis in 2004. Wess is a
member of the editorial board for
ChemBioChem and was co-editor of
three special issues of this journal:
“Systems Biology & Chemistry” (10/
2004), “RNA Targeting” (10/2003), and
“G-Protein-Coupled Receptors” (10/
2002). He also highlighted the prospects
and challenges in medicinal chemistry in
an essay that appeared in Angewandte
Chemie in 2001.[3]
[1] D. B. Werz, P. H. Seeberger, Angew.
Chem. 2005, 117, 6474; Angew. Chem.
Int. Ed. 2005, 44, 6315.
[2] R. W. Hoffmann, J. Lanz, R. Metternich,
G. Tarara, D. Hoppe, Angew. Chem. 1987,
99, 1196; Angew. Chem. Int. Ed. Engl.
1987, 26, 1145.
[3] G. Wess, M. Urmann, B. Sickenberger,
Angew. Chem. 2001, 113, 3443; Angew.
Chem. Int. Ed. 2001, 40, 3341.
DOI: 10.1002/anie.200503723
Angew. Chem. Int. Ed. 2005, 44, 7330
Документ
Категория
Без категории
Просмотров
1
Размер файла
170 Кб
Теги
chemistry, medicina, wess, seeberger, board, recognize, direct, combinatorics, pharmaceutical, gsf, metternich
1/--страниц
Пожаловаться на содержимое документа